Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Insiders Buying Hillenbrand And 2 Other Stocks

Published 05/12/2023, 14:18
Updated 05/12/2023, 15:40
© Reuters.  Insiders Buying Hillenbrand And 2 Other Stocks
HI
-
HSDT
-

Benzinga - by Lisa Levin, Benzinga Editor.

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Citi Trends

  • The Trade: Citi Trends, Inc. (NASDAQ: CTRN) 10% owner Pleasant Lake Onshore Feeder Fund LP acquired a total of 78,724 shares an average price of $23.75. To acquire these shares, it cost around $1.87 million. The company’s Director also sold 12,000 shares of the company.
  • What’s Happening: On Nov. 28, Citi Trends reported a third-quarter sales decline of 6.7% year-on-year to $179.52 million compared to $192.32 million last year.
  • What Citi Trends Does: Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States.
Hillenbrand
  • The Trade: Hillenbrand, Inc. (NYSE: HI) Director Helen W Cornell acquired a total of 6,491 shares at an average price of $38.43. To acquire these shares, it cost around $249,423.
  • What’s Happening: On Nov. 15, Hillenbrand posted better-than-expected results for its fourth quarter.
  • What Hillenbrand Does: Hillenbrand Inc is a U.S.-based company that operates through three segments.
Don’t forget to check out our premarket coverage here

Helius Medical Technologies

  • The Trade: Helius Medical Technologies, Inc. (NASDAQ: HSDT) President and CEO Dane Andreeff bought a total of 4,006 shares at an average price of $6.41. To acquire these shares, it cost around $25,675.
  • What’s Happening: On Nov. 9, Helius Medical Tech posted a narrower-than-expected loss for the third quarter.
  • What Helius Medical Technologies Does: Helius Medical Technologies Inc is a neurotech company focused on neurological wellness.

Check This Out: Top 4 Financial Stocks That May Fall Off A Cliff In Q4

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.